The photon optimization (PO) algorithm was recently released by Varian Medical Systems to improve volumetric modulated arc therapy (VMAT) optimization within Eclipse (Version 13.5). The purpose of this study is to compare the PO algorithm with its predecessor, progressive resolution optimizer (PRO) for lung SBRT and brain SRS treatments. A total of 30 patients were selected retrospectively. Previously, all the plans were generated with the PRO algorithm within Eclipse Version 13.6. In the new version of PO algorithm (Version 15), dynamic conformal arcs (DCA) were first conformed to the target, then VMAT inverse planning was performed to achieve the desired dose distributions. PTV coverages were forced to be identical for the same patient for a fair comparison. SBRT plan quality was assessed based on selected dose-volume parameters, including the conformity index, V 20 for lung, V 30 Gy for chest wall, and D 0.035 cc for other critical organs. SRS plan quality was evaluated based on the conformity index and normal tissue volumes encompassed by the 12 and 6 Gy isodose lines (V 12 and V 6 ). The modulation complexity score (MCS) was used to compare plan complexity of two algorithms. No statistically significant differences between the PRO and PO algorithms were found for any of the dosimetric parameters studied, which indicates both algorithms produce comparable plan quality. Significant improvements in the gamma passing rate (increased from 97.0% to 99.2% for SBRT and 96.1% to 98.4% for SRS), MCS (average increase of 0.15 for SBRT and 0.10 for SRS), and delivery efficiency (MU reduction of 29.8% for SBRT and 28.3% for SRS) were found for the PO algorithm. MCS showed a strong correlation with the gamma passing rate, and an inverse correlation with total MUs used. The PO algorithm offers comparable plan quality to the PRO, while minimizing MLC complexity, thereby improving the delivery efficiency and accuracy.
| INTRODUCTION
In the past decade, stereotactic radiation therapy has been increasingly used in the management of both intracranial (stereotactic radiosurgery, SRS) and extracranial tumors (stereotactic body radiation therapy, SBRT). This technique is able to precisely deliver very high doses to the tumors while sparing the adjacent normal tissues in just a few fractions, and has been proven to provide superior or comparable treatment outcomes and is cost-effective relative to alternative conventional techniques. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Several delivery options have been implemented in Linac-based stereotactic treatments, including noncoplanar three-dimensional conformal radiation therapy (3D-CRT), dynamic conformal arcs (DCA), intensity modulated radiation therapy (IMRT, including sliding window and step-and-shoot techniques), and volumetric modulated arc therapy (VMAT). Recently DCA and VMAT have become popular due to their delivery efficiency compared to 3D-CRT and IMRT. For DCA treatment, the multileaf collimator (MLC) is shaped to conform to the planning target volume (PTV) based on the beam's eye view (BEV) as the gantry rotates around the patient. The gantry speed and dose rate remain constant during the DCA delivery.
Volumetric modulated arc therapy was first introduced and implemented into the clinic as a novel radiation delivery technique 11, 12 that was a variation on static field IMRT. Unlike DCA, VMAT plans are generated by an inverse planning algorithm, which allows modulation of the gantry rotation speed, dose rate, and also the position and speed of MLC. It is recommended that VMAT plans always be validated with a patient-specific QA measurement before treatment. Compared to VMAT, DCA techniques offer advantages in terms of reduced multileaf collimator (MLC) motion complexity, positioning error, and delivery efficiency, thus DCA may be the desired delivery modality from a technical treatment delivery viewpoint. However, VMAT may be favored due to its increased ability for dose shaping when certain critical organs sparing becomes important.
The photon optimization (PO) algorithm was recently released by Varian Medical System (Palo Alto, CA, USA) to improve IMRT and VMAT optimizations in Eclipse treatment planning system (TPS) version 13.5. The PO algorithm combines the dose-volume optimizer (DVO) used for static field IMRT and the progressive resolution optimizer (PRO) used for VMAT plans from the previous Eclipse version.
Both PRO and PO algorithms create VMAT plans based on dosevolume objectives, and generate a sequence of control points, which define MLC leaf positions and MU/degree as a function of gantry angle. For both PRO and PO algorithms, the initial conditions are defined using control points to represent each VMAT field; a multiresolution approach and an objective function (the sum of the dose-volume and user-defined objectives) are used to optimize the plan. The multiresolution dose calculation (MRDC) algorithm is used to increase the dose calculation accuracy with progressive dose calculation segments using a point cloud-based model. 13 The optimization process goes through four multiresolution level, in which number of dose calculation segments increase progressively at each level. The number of control points keeps unchanged during the whole optimization process.
The main difference of the PO algorithm from the PRO algorithm is that instead of using a point cloud mode for defining structures in Each clinical plan was normalized such that at least 95% of the PTV received the prescription dose, and more than 99% of the PTV received at least 90% of the prescription dose. The maximum point dose and dose-volume constraints of several critical organs are listed in Table 1 for both 54 and 50 Gy protocols. [14] [15] [16] All SRS patients were immobilized in BrainLab SRS masks (BrainLab AG, Feldkirchen, Germany) and received IV contrast prior to the CT scan when possible. All patients also underwent MR scans, which were registered with the planning CT to define the gross tumor volume (GTV). The GTV was expanded by 1 mm margin uniformly to form the PTV. MR scans were acquired on a GE Signa EXCITE 3.0T
MRI scanner (GE Healthcare, Waukesha, WI, USA) with 1 mm slice thickness and a field of view large enough to include the entire surface of the patient. Postcontrast T1-weighted axial scans were used for all cases. 6X-FFF beams with 3-4 table kicks were used for the original clinical VMAT plans, and at least 99% of PTV and 100%
GTV coverages were enforced. The maximum point dose and dosevolume constraints for critical structures followed the guidelines of AAPM TG-101. 14 All the clinical plans were optimized in Eclipse version 13.6 with the PRO algorithm, which is based on dose-volume objectives. All plans were reoptimized with the new PO algorithm in Eclipse version 15, which offers a VMAT optimization based on an initial DCA plan as described above. The PO algorithm determines the optimal field shape and intensity by interactively conforming the dose distribution to the desired objectives until an optimum solution is reached. In the new PO algorithm, DCA was first used to conform to the target and followed by VMAT inverse planning to achieve the desired dose distribution.
The DCA beams were automatically fit with 3-4 mm margin around the PTV, and the same beam configurations (gantry, collimator and table angles) were used in the re-plan. In order to isolate the variation due to the planning optimization algorithm, the same planning objectives, constraints, and weightings for the target and critical organs were used for both the PRO and PO plans. The settings were also retained for normal tissue optimization (NTO) and the MU objectives.
PTV coverage was forced to be identical for the same patient in order to have a comparison between the PRO and PO algorithms (at least 95% for lung SBRT and 99% for SRS patients and then modified by Masi in order to apply for VMAT plans (considering control points of the arc instead of segments). 18 The plan complexity analysis (MCS and AA) was implemented as a plug-in script to the Varian Eclipse planning system. Higher MCS and AA values mean less plan complexity, and easier plan deliverability.
Agreement of the planning and delivered doses was assessed by studying the patient-specific QA results. Patient-specific QA was performed with ArcCHECK (Sun Nuclear) and gamma passing rates were compared between the PRO and PO plans. The criteria for gamma analysis were 3%/3 mm and 2%/2 mm for SBRT plans, and 5%/1 mm and 3%/1 mm for SRS plans with 10% threshold. The
Mann-Whitney U test was used to evaluate the differences between the two groups of plans for MCS, total MUs used, gamma passing rate, and dosimetric parameters for critical structures.
All work was carried with the approval of the institutional review board under protocol number 1767.
| RESULTS
The average volume of the PTV for SBRT patients was 34.1 AE 12.5 cc (range from 10.1 to 54.2 cc) and 30.8 AE 18.1 cc (range from 9.7 to 59.5 cc) for 54 and 50 Gy treatments, respectively. The average volume of the PTV was 10.1 AE 10.3 cc (range from 0.9 to 31.4 cc) for SRS patients. Table 2 lists the distribution of the tumor locations and target coverage for the group of the patients included in this analysis. Mann-Whitney U tests were performed between the two algorithm groups, and the resulting P-values are listed in Table 4 for both SBRT and SRS treatments. No statistically significant differences between the two algorithms were found for CI 50 or doses to critical structures for SBRT patients (P >> 0.05 from the MannWhitney U test). The same conclusion can be drawn with regard to the differences between two algorithms for CI 100 and the ratio of V 12 , V 6 , and V 3 for SRS patients. This indicates the PRO and PO algorithms produce very similar plan quality for the stereotactic treatments.
As can be seen from Table 4 , statistically significant improvements in the MLC modulation (larger MCS value), delivery efficiency (reduced total MUs), and better agreement between the planned and delivered doses (improved gamma passing rate) were found for the new PO method. The MCS showed a strong correlation with gamma passing rate and an inverse correlation with the total MUs used in the plan.
| DISCUSSION
Currently, DCA and VMAT are two of the most frequently used techniques in stereotactic treatment planning. DCA may be considered desirable due to advantages over VMAT including minimizing the MLC motion, position error, and delivery efficiency, etc. However, in some cases, VMAT may be able to provide more conformal from the earlier PRO algorithm is that PO algorithm uses a new method to model the structure, which allows the user to optimize the VMAT plans directly from DCA beams. The purpose of this study is to compare the new photon optimization algorithm using a DCA initialization with its predecessor, the progressive resolution optimizer, in terms of MLC modulation, delivery efficiency, and agreement between the planned and delivered doses for both lung SBRT and brain SRS patients.
As shown in Table 4 , no statistically significant differences (P << 0.05 from Mann-Whitney U test) were found for any of the dosimetric parameters between the PO and PRO algorithms (the target coverages were forced to be identical for both algorithms for a similar comparison), indicating both algorithms had comparable plan quality. Compared to the PRO plans, statistical significant improvements (P < 0.05) were found for the PO plans in terms of MLC modulation (MCS and AA), total MUs used, and the gamma passing rate for the patient-specific QA.
Two metrics, MCS (between 0 and 1) and AA, were used to evaluate the overall plan complexity for both PRO and PO plans. The In our clinical practice, the guideline for passing the patient-specific QA is c > 95% at 3%/3 mm for SBRT and 5%/1 mm for SRS treatments, respectively. Better agreement between the planned and delivered doses (c increased from 97.0% to 99.2% at 3%/3 mm criteria for SBRT plans and from 96.1% to 98.4% at 5%/1 mm criteria for SRS plans) were found for the PO plans. Results from tighter criteria (2%/2 mm for SBRT and 3%/1 mm for SRS) were also included in our analysis to gain more insight of the deviation of planned and delivered dose. Compared to the PRO plans, c of PO plans increased from 93.0% to 96.8% at 2%/2 mm criteria for SBRT plans and from 90.6% to 95.7% at 3%/1 mm criteria for SRS plans.
Better QA results from PO plans can be attributed to reduced plan modulation (MCS and AA) for the new PO algorithm, which is consistent with previous a finding. 18 The MSC for VMAT plans was originally defined by McNiven for stepand-shoot IMRT plans, 17 and then modified by Masi in order to apply for VMAT plans. 18 The LSV is defined based on the difference in position for adjacent MLC leaves in the same bank for each control point ( where N is the number of moving leaves and pos n is the position of leaf n.
The AAV is based on the area defined by opposing MLC leaves in a CP normalized to the maximum area in the arc, which is defined by the maximum apertures for all leaf pairs over all CPs in the arc where I is the number of CP and MU CPi,i+1 are the MU delivered between two consecutive CPs.
The AA term is defined using the notation from above as 
